{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:27:43Z","timestamp":1791232063340,"version":"4.1.0"},"reference-count":74,"publisher":"Impact Journals, LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2009,2,11]]},"DOI":"10.18632\/aging.100021","type":"journal-article","created":{"date-parts":[[2016,3,6]],"date-time":"2016-03-06T03:26:52Z","timestamp":1457234812000},"page":"234-244","source":"Crossref","is-referenced-by-count":79,"title":["Cyclooxygenase-1 null mice show reduced neuroinflammation in response to \u03b2-amyloid"],"prefix":"10.18632","volume":"1","author":[{"given":"Sang-Ho","family":"Choi","sequence":"first","affiliation":[{"name":"Molecular Neuroscience Unit, Brain Physiology and Metabolism Section, National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bosetti","sequence":"additional","affiliation":[{"name":"Molecular Neuroscience Unit, Brain Physiology and Metabolism Section, National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2009,2,11]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nature02621","article-title":"Pathways towards and away from Alzheimer's disease","volume":"43","author":"Mattson","year":"2004","journal-title":"Nature"},{"key":"2","first-page":"1135","article-title":"Cyclooxygenase-1 in human Alzheimer and control brain: quantitative analysis of expression by microglia and CA3 hippocampal neurons","volume":"5","author":"O'Banion","year":"1999","journal-title":"J Neuropathol Exp Neurol"},{"key":"3","first-page":"323","article-title":"Elevated CSF prostaglandin E2 levels in patients with probable AD","volume":"5","author":"Morrow","year":"2000","journal-title":"Neurology"},{"key":"4","first-page":"2","article-title":"Cyclooxygenase expression in microglia and neurons in Alzheimer's disease and control brain","volume":"10","author":"Eikelenboom","year":"2001","journal-title":"Acta Neuropathol (Berl)"},{"key":"5","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/jnen\/63.9.901","article-title":"Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases","volume":"6","author":"Minghetti","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"6","first-page":"85","article-title":"Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease","volume":"7","author":"Minghetti","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7","first-page":"1441","article-title":"Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study","volume":"4","author":"Hofman","year":"1995","journal-title":"Neurology"},{"key":"8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1212\/WNL.47.2.425","article-title":"Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies","volume":"4","author":"McGeer","year":"1996","journal-title":"Neurology"},{"key":"9","first-page":"626","article-title":"Risk of Alzheimer's disease and duration of NSAID use","volume":"4","author":"Metter","year":"1997","journal-title":"Neurology"},{"key":"10","first-page":"2066","article-title":"Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: the Cache County study","volume":"5","author":"Stone","year":"2000","journal-title":"Neurology"},{"key":"11","first-page":"1515","article-title":"Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease","volume":"34","author":"Stricker","year":"2001","journal-title":"N Engl J Med"},{"key":"12","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neurobiolaging.2006.03.013","article-title":"NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies","volume":"2","author":"McGeer","year":"2007","journal-title":"Neurobiol Aging"},{"key":"13","first-page":"1672","article-title":"Protective effects of NSAIDs on the development of Alzheimer disease","volume":"7","author":"Felson","year":"2008","journal-title":"Neurology"},{"key":"14","first-page":"1609","article-title":"Clinical trial of indomethacin in Alzheimer's disease","volume":"4","author":"Willson","year":"1993","journal-title":"Neurology"},{"key":"15","first-page":"197","article-title":"A double-blind, placebo-controlled trial of diclofenac\/misoprostol in Alzheimer's disease","volume":"5","author":"Christophidis","year":"1999","journal-title":"Neurology"},{"key":"16","first-page":"2819","article-title":"Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial","volume":"28","author":"Thal","year":"2003","journal-title":"Jama"},{"key":"17","first-page":"66","article-title":"Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study","volume":"6","author":"Baranak","year":"2004","journal-title":"Neurology"},{"key":"18","first-page":"1204","article-title":"A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment","volume":"3","author":"Reines","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"19","first-page":"2197","article-title":"Modulation of nuclear factor-kappa B activity by indomethacin influences A beta levels but not A beta precursor protein metabolism in a model of Alzheimer's disease","volume":"16","author":"Pratico","year":"2004","journal-title":"Am J Pathol"},{"key":"20","first-page":"651","article-title":"Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity","volume":"13","author":"Ashe","year":"2008","journal-title":"Brain"},{"key":"21","first-page":"2246","article-title":"Microglial activation and beta -amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice","volume":"2","author":"Gordon","year":"2002","journal-title":"J Neurosci"},{"key":"22","first-page":"545","article-title":"Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production","volume":"1","author":"Golde","year":"2005","journal-title":"Nat Med"},{"key":"23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1742-2094-5-17","article-title":"Neuroinflammatory response to lipopolysaccharide is exacerbated in mice genetically deficient in cyclooxygenase-2","volume":"5","author":"Bosetti","year":"2008","journal-title":"J Neuroinflammation"},{"key":"24","first-page":"440","article-title":"NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo","volume":"11","author":"Golde","year":"2003","journal-title":"J Clin Invest"},{"key":"25","first-page":"337","article-title":"Modulation of beta-amyloid metabolism by non-steroidal anti-inflammatory drugs in neuronal cell cultures","volume":"8","author":"Ongini","year":"2004","journal-title":"J Neurochem"},{"key":"26","first-page":"1111","article-title":"Ibuprofen suppresses interleukin-1beta induction of pro-amyloidogenic alpha1-antichymotrypsin to ameliorate beta-amyloid (Abeta) pathology in Alzheimer's models","volume":"3","author":"Cole","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"27","first-page":"5705","article-title":"Synthesis and biological activity of flurbiprofen analogues as selective inhibitors of beta-amyloid(1)(-)(42) secretion","volume":"4","author":"Imbimbo","year":"2005","journal-title":"J Med Chem"},{"key":"28","first-page":"925","article-title":"Substrate-targeting gamma-secretase modulators","volume":"45","author":"Golde","year":"2008","journal-title":"Nature"},{"key":"29","first-page":"2291","article-title":"No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies","volume":"7","author":"Zandi","year":"2008","journal-title":"Neurology"},{"key":"30","first-page":"93","article-title":"Animal models of Alzheimer's disease and evaluation of anti-dementia drugs","volume":"8","author":"Nabeshima","year":"2000","journal-title":"Pharmacol Ther"},{"key":"31","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1471-4159.2007.04558.x","article-title":"Arachidonic acid metabolism in brain physiology and pathology: lessons from genetically altered mouse models","volume":"10","author":"Bosetti","year":"2007","journal-title":"J Neurochem"},{"key":"32","first-page":"89","article-title":"Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid","volume":"13","author":"Song","year":"2001","journal-title":"Br J Pharmacol"},{"key":"33","first-page":"185","article-title":"Beta-amyloid (1-42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex","volume":"15","author":"Woo","year":"2004","journal-title":"Behav Brain Res"},{"key":"34","first-page":"205","article-title":"Differential susceptibility following beta-amyloid peptide-(1-40) administration in C57BL\/6 and Swiss albino mice: Evidence for a dissociation between cognitive deficits and the glutathione system response","volume":"17","author":"Dafre","year":"2007","journal-title":"Behav Brain Res"},{"key":"35","first-page":"5394","article-title":"Connecting TNF-alpha signaling pathways to iNOS expression in a mouse model of Alzheimer's disease: relevance for the behavioral and synaptic deficits induced by amyloid beta protein","volume":"2","author":"Calixto","year":"2007","journal-title":"J Neurosci"},{"key":"36","first-page":"37","article-title":"Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration","volume":"75","author":"Slikker","year":"1997","journal-title":"Brain Res"},{"key":"37","first-page":"1491","article-title":"Genetic deletion or pharmacological inhibition of cyclooxygenase-1 attenuate lipopolysaccharide-induced inflammatory response and brain injury","volume":"2","author":"Bosetti","year":"2008","journal-title":"Faseb J"},{"key":"38","first-page":"685","article-title":"RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease","volume":"38","author":"Schmidt","year":"1996","journal-title":"Nature"},{"key":"39","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/70978","article-title":"Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease","volume":"5","author":"Przedborski","year":"1999","journal-title":"Nat Med"},{"key":"40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","article-title":"Microglia-mediated neurotoxicity: uncovering the molecular mechanisms","volume":"8","author":"Hong","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"41","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0304-3940(87)90696-3","article-title":"Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR","volume":"7","author":"McGeer","year":"1987","journal-title":"Neurosci Lett"},{"key":"42","first-page":"491","article-title":"Microglia in diseases of the central nervous system","volume":"3","author":"Lavi","year":"2002","journal-title":"Ann Med"},{"key":"43","first-page":"1050","article-title":"Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress","volume":"3","author":"Lauderback","year":"2002","journal-title":"Free Radic Biol Med"},{"key":"44","first-page":"1394","article-title":"Proteomic identification of nitrated proteins in Alzheimer's disease brain","volume":"8","author":"Butterfield","year":"2003","journal-title":"J Neurochem"},{"key":"45","first-page":"8126","article-title":"Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation","volume":"1","author":"Floyd","year":"1998","journal-title":"J Neurosci"},{"key":"46","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1750-3639.1999.tb00215.x","article-title":"Oxidative alterations in Alzheimer's disease","volume":"9","author":"Carney","year":"1999","journal-title":"Brain Pathol"},{"key":"47","first-page":"2653","article-title":"Widespread peroxynitrite-mediated damage in Alzheimer's disease","volume":"1","author":"Perry","year":"1997","journal-title":"J Neurosci"},{"key":"48","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1089\/ars.2006.8.2021","article-title":"Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics","volume":"8","author":"Butterfield","year":"2006","journal-title":"Antioxid Redox Signal"},{"key":"49","first-page":"883","article-title":"Gene regulation and DNA damage in the ageing human brain","volume":"42","author":"Yankner","year":"2004","journal-title":"Nature"},{"key":"50","first-page":"1","article-title":"The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina","volume":"4","author":"Michaelsen","year":"2001","journal-title":"Prog Lipid Res"},{"key":"51","first-page":"565","article-title":"Essential fatty acids are mediators of brain biochemistry and cognitive functions","volume":"5","author":"Mostofsky","year":"1999","journal-title":"J Neurosci Res"},{"key":"52","first-page":"949","article-title":"Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease","volume":"4","author":"Farlow","year":"2005","journal-title":"J Lipid Res"},{"key":"53","first-page":"399","article-title":"Immunocytochemical evidence that amyloid beta (1-42) impairs endogenous antioxidant systems in vivo","volume":"11","author":"Nabeshima","year":"2003","journal-title":"Neuroscience"},{"key":"54","first-page":"2161","article-title":"Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo","volume":"1","author":"Mantyh","year":"1998","journal-title":"J Neurosci"},{"key":"55","first-page":"314","article-title":"Neurotoxicity and oxidative damage of beta amyloid 1-42 versus beta amyloid 1-40 in the mouse cerebral cortex","volume":"89","author":"Ferrante","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"56","first-page":"552","article-title":"Minocycline or iNOS inhibition block 3-nitrotyrosine increases and blood-brain barrier leakiness in amyloid beta-peptide-injected rat hippocampus","volume":"19","author":"McLarnon","year":"2006","journal-title":"Exp Neurol"},{"key":"57","first-page":"1","article-title":"Delayed behavioral effects following intrahippocampal injection of aggregated A beta (1-42)","volume":"81","author":"Cleary","year":"1999","journal-title":"Brain Res"},{"key":"58","first-page":"128","article-title":"Progressive brain dysfunction following intracerebroventricular infusion of beta(1-42)-amyloid peptide","volume":"91","author":"Ohno","year":"2001","journal-title":"Brain Res"},{"key":"59","first-page":"164","article-title":"Abeta(1-42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT(2A) levels","volume":"21","author":"Aznar","year":"2008","journal-title":"Exp Neurol"},{"key":"60","first-page":"1415","article-title":"NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia","volume":"27","author":"Hong","year":"2004","journal-title":"J Biol Chem"},{"key":"61","first-page":"218","article-title":"The role of cyclo-oxygenase 1 and 2 activity in prostaglandin E(2) secretion by cultured human adult microglia: implications for Alzheimer's disease","volume":"95","author":"Eikelenboom","year":"2002","journal-title":"Brain Res"},{"key":"62","first-page":"2099","article-title":"Neurones treated with cyclo-oxygenase-1 inhibitors are resistant to amyloid-beta1-42","volume":"1","author":"Williams","year":"2003","journal-title":"Neuroreport"},{"key":"63","first-page":"130","article-title":"Purification, characterization and selective inhibition of human prostaglandin G\/H synthase 1 and 2 expressed in the baculovirus system","volume":"120","author":"Freire","year":"1994","journal-title":"Biochim Biophys Acta"},{"key":"64","first-page":"1419","article-title":"Cyclooxygenase-1 and -2 in the different stages of Alzheimer's disease pathology","volume":"1","author":"Eikelenboom","year":"2008","journal-title":"Curr Pharm Des"},{"key":"65","first-page":"488","article-title":"Cyclooxygenase inhibition limits blood-brain barrier disruption following intracerebral injection of tumor necrosis factor-alpha in the rat","volume":"32","author":"Rosenberg","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"66","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2174\/1389450033490902","article-title":"Non-steroidal anti-inflammatory drugs and cyclooxygenase in Alzheimer's disease","volume":"4","author":"Eikelenboom","year":"2003","journal-title":"Curr Drug Targets"},{"key":"67","first-page":"483","article-title":"Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration","volume":"8","author":"Smithies","year":"1995","journal-title":"Cell"},{"key":"68","doi-asserted-by":"crossref","first-page":"R14","DOI":"10.1186\/gb-2007-8-1-r14","article-title":"Differential gene expression patterns in cyclooxygenase-1 and cyclooxygenase-2 deficient mouse brain","volume":"8","author":"Bosetti","year":"2007","journal-title":"Genome Biol"},{"key":"69","first-page":"181","article-title":"Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction","volume":"70","author":"Privat","year":"1996","journal-title":"Brain Res"},{"key":"70","volume-title":"The mouse brain in stereotaxic coordinates. edn 2nd","author":"Franklin","year":"2001"},{"key":"71","first-page":"4082","article-title":"Thrombin-induced oxidative stress contributes to the death of hippocampal neurons in vivo: role of microglial NADPH oxidase","volume":"2","author":"Jin","year":"2005","journal-title":"J Neurosci"},{"key":"72","first-page":"123","article-title":"Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration","volume":"87","author":"Hopkins","year":"2000","journal-title":"Brain Res"},{"key":"73","first-page":"432","article-title":"Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease","volume":"1","author":"Luster","year":"2007","journal-title":"Nat Med"},{"key":"74","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0003-2697(85)90628-1","article-title":"Reversed-phase high-pressure liquid chromatography of arachidonic acid metabolites formed by cyclooxygenase and lipoxygenases","volume":"14","author":"Powell","year":"1985","journal-title":"Anal Biochem"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.100021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T20:28:54Z","timestamp":1718396934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.100021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,11]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["100021","20157512"],"URL":"https:\/\/doi.org\/10.18632\/aging.100021","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,11]]}}}